Impact of treatment planning and delivery factors on gastrointestinal toxicity: an analysis of data from the RADAR prostate radiotherapy trial

- Yahya, Noorazrul, Ebert, Martin A., Denham, Jim W., Bulsara, Max, Haworth, Annette, Kearvell, Rachel, Foo, Kerwyn, Kennedy, Angel, Richardson, Sharon, Krawiec, Michele, Joseph, David J.

Dosimetry, clinical factors and medication intake influencing urinary symptoms after prostate radiotherapy: an analysis of data from the RADAR prostate radiotherapy trial

- Yahya, Noorazul, Ebert, Martin A., Bulsara, Max, Haworth, Annette, Kennedy, Angel, Joseph, David J., Denham, Jim W.

Impact of selection of post-implant technique on dosimetry parameters for permanent prostate implants

- Haworth, Annette, Ebert, Martin A., St. Clair, Shaun, Carey, Brendan M., Flynn, Anthony, Bottomley, David M., Duchesne, Gillian M., Joseph, David, Ash, Daniel

Gastrointestinal dose-histogram effects in the context of dose-volume-constrained prostate radiation therapy: analysis of data from the radar prostate radiation therapy trial

- Ebert, Martin A., Foo, Kerwyn, Haworth, Annette, Gulliford, Sarah L., Kennedy, Angel, Joseph, David J., Denham, James W.

Quality improvements in prostate radiotherapy: outcomes and impact of comprehensive quality assurance during the TROG 03.04 'RADAR' trial

- Kearvell, Rachel, Haworth, Annette, Denham, James W., Ebert, Martin A., Murray, Judy, Hooton, Ben, Richardson, Sharon, Joseph, David J., Lamb, David, Spry, Nigel A., Duchesne, Gillian

Prostate implant evaluation using tumour control probability: the effect of input parameters

- Haworth, Annette, Ebert, Martin, Waterhouse, David, Joseph, David, Duchesne, Gillian

Assuring high quality treatment delivery in clinical trials: results from the Trans-Tasman Radiation Oncology Group (TROG) study 03.04 "RADAR" set-up accuracy study

- Haworth, Annette, Kearvell, Rachel, Greer, Peter B., Hooton, Ben, Denham, James W., Lamb, David, Duchesne, Gillian, Murray, Judy, Joseph, David

A virtual dosimetry audit - towards transferability of gamma index analysis between clinical trial QA groups

- Hussein, Mohammad, Clementel, Enrico, Nakamura, Mitsuhiro, Hurkmans, Coen, Clark, Catherine H., Global Quality Assurance of Radiation Therapy Clinical Trial Harmonisation Group,, Eaton, David J., Greer, Peter B., Haworth, Annette, Ishikura, Satoshi, Kry, Stephen F., Lehmann, Joerg, Lye, Jessica, Monti, Angelo F.

Optimizing radiation therapy quality assurance in clinical trials: a TROG 08.03 RAVES substudy

- Trada, Yuvnik, Kneebone, Andrew, Paneghel, Andrea, Pearse, Maria, Sidhom, Mark, Tang, Colin, Wiltshire, Kirsty, Haworth, Annette, Fraser-Browne, Carol, Martin, Jarad

Radiation dose escalation or longer androgen suppression for locally advanced prostate cancer? Data from the TROG 03.04 RADAR trial

- Denham, James W., Steigler, Allison, Tai, Keen-Hun, Gogna, Nirdosh Kumar, Gill, Suki, Tan, Hendrick, Kearvell, Rachel, Murray, Judy, Ebert, Martin, Haworth, Annette, Kennedy, Angel, Delahunt, Brett, Joseph, David, Oldmeadow, Christopher, Holliday, Elizabeth G., Attia, John, Lamb, David S., Spry, Nigel A., Duchesne, Gillian, Atkinson, Chris, Matthews, John, Turner, Sandra, Kenny, Lizbeth

A randomised trial investigating the effect on biochemical (PSA) control and survival of different durations of adjuvant androgen deprivation in association with definitive radiation treatment for localised carcinoma of the prostate

- Lamb, David, Joesph, David, Turner, Sandra, Diamond, Terry, Steigler, Allison, Attia, John, Delahunt, Brett, Haworth, Annette, Denham, Jim, Duchesne, Gillian, Atkinson, Chris, Kenny, Lizbeth, Gogna, Kumar, Matthews, John, Spry, Nigel, Tai, Keen-Hun

Technical quality assurance during the TROG 03.04 RADAR prostate radiotherapy trial: are the results reflected in observed toxicity rates?

- Ebert, Martin A., Bulsara, Max, Haworth, Annette, Kearvell, Rachel, Richardson, Sharon, Kennedy, Angel, Spry, Nigel A., Bydder, Sean A., Joseph, David J., Denham, James W.